gip/glp 1-agonist tirzepatide (GLP-1 / GIP) GLP-1/GIP dual agonist tirzepatide alleviates

Its chemical structure alteration, incorporating an acetyl group, enables it to traverse the blood-brain barrier, promoting brain health and energy production simultaneously

doi:10.1038/s41522-025-00712-y Yoon HS, Cho CH, Yun MS, et al

Dietary sodium chloride intake independently predicts the degree of hyperchloremic metabolic acidosis in healthy humans consuming a net acid-producing diet

Research shows that when people stop a GLP-1 medication suddenly without having built those habits, some weight regain is likely

Excess weight gain can compromise the effectiveness of the treatment and lead to recurrence of fat deposits

Serious Side Effects Though rare, some individuals may experience more severe side effects, such as: Allergic reactions: Include rash, itching, or swelling, particularly of the face, tongue, or throat